BioCube, Inc.
BICB
$0.0002
-$0.0022-91.67%
| 07/31/2013 | 04/30/2013 | 01/31/2013 | 10/31/2012 | 07/31/2012 | |
|---|---|---|---|---|---|
| Net Income | -914.10K | -903.40K | -764.50K | -566.50K | -286.20K |
| Total Depreciation and Amortization | 436.80K | 436.80K | 289.30K | 101.50K | 101.50K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 0.00 | -3.50K | -101.50K |
| Total Other Non-Cash Items | 68.10K | -8.30K | 29.20K | 112.70K | -42.40K |
| Change in Net Operating Assets | 408.70K | 413.70K | 384.60K | 289.40K | 256.40K |
| Cash from Operations | -500.00 | -61.20K | -61.40K | -66.40K | -72.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 60.00K | 60.00K | 65.00K | 70.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 60.00K | 60.00K | 65.00K | 70.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -500.00 | -1.20K | -1.40K | -1.40K | -2.20K |
